March 10th, 2026
Pro-Resolving Chemical Mediators and Mechanisms in Resolution of Inflammation: Novel Resolvins for Resolution Medicine
Prof. Charles N. Serhan, Brigham & Women’s Hospital, Harvard Medical School, Boston, USA
Unanticipated Pivotal Roles for Neutrophils in the Resolution of Lung Injury and Inflammation
Prof. Bruce D. Levy, Brigham & Women’s Hospital, Harvard Medical School, Boston, USA
From Culprits to Resolvers: Lipids in Cardiovascular Disease
Prof. Magnus Bäck, Karolinska Institutet, Stockholm, Sweden
Inflammatory resolution mechanisms in cardiometabolic health and disease
Ass. Prof. Emma Börgeson, Aarhus University, Denmark
RvD1 signaling in primary human macrophages
Prof. Martin Hersberger, Universität Zürich, Switzerland
Biosynthesis and structure–function relationships of protectins
Prof. Trond V. Hansen, University of Oslo, Norway
Resolvins under the hood: methods and metabolism
Dr. Pedro Araujo, Institute of Marine Research, Bergen, Norway
Targeting the lipid mediator class switch as strategy for inflammation resolution pharmacology
Prof. Oliver Werz, Jena University, Germany
March 11th, 2026
SPMs & the Resolution of Cancer Inflammation
Ass. Prof. Dipak Panigrahy, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
Resolving inflammation in Cardiovascular Disease
Prof. Bente Halvorsen, University of Oslo, Norway
Resolvin D1 reshapes immune cell dynamics and reprograms neuroglial interactions in Parkinson's disease
Ass. Prof. Valerio Chiurchiù, IRCCS Santa Lucia Foundation, Rome, Italy
Resolution of inflammation: Future directions in science, innovations and clinics
Panel discussion: Prof. Charles N. Serhan, Ass. Prof. Emma Börgeson, Prof. Jesper Haeggström. Moderator: Prof. Trond V. Hansen.